Sander Van Deventer
Chief Scientific Officer
pharmaceutical Science
uniQure
Netherlands
Biography
Dr. Sander van Deventer joined uniQure as Chief Scientific Officer, General Manager, Amsterdam in August, 2017. Dr. van Deventer was a co-founder of uniQure's predecessor Amsterdam Molecular Therapeutics (AMT) in 1998 and Board member since 2010.
Research Interest
Pharmaceutical Sciences & Emerging Drugs